François Fasquelle

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma

C. Borel, M. Masson, N. Etienne-Selloum, 2021, Cancers.

Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review

A. Digklia, Christine Sempoux, Clarisse Dromain, 2024, Cancers.

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

C. Sempoux, O. Michielin, D. Moradpour, 2022, Journal for ImmunoTherapy of Cancer.

The “Real R0”: A Resection Margin Smaller Than 0.1 cm is Associated with a Poor Prognosis After Oncologic Esophagectomy

M. Schäfer, N. Demartines, C. Sempoux, 2021, Annals of Surgical Oncology.

The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis

M. Hübner, F. Fasquelle, L. Toussaint, 2023, Pleura and peritoneum.